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Structural model of phospholipid-reconstituted human
transferrin receptor derived by electron microscopy
Hendrik Fuchs1†, Uwe Lücken2‡, Rudolf Tauber1†, Andreas Engel3
and Reinhard Geßner1*
Background:  The transferrin receptor (TfR) regulates the cellular uptake of
serum iron. Although the TfR serves as a model system for endocytosis
receptors, neither crystal structure analysis nor electron microscopy has yet
revealed the molecular dimensions of the TfR. To derive the first molecular
model, we analyzed purified, lipid-reconstituted human TfR by high-resolution
electron microscopy.
Results:  A structural model of phospholipid-reconstituted TfR was derived
from 72 cryo-electron microscopic images. The TfR dimer consists of a large
extracellular globular domain (6.4 × 7.5 × 10.5 nm) separated from the
membrane by a thin molecular stalk (2.9 nm). A comparative protein sequence
analysis suggests that the stalk corresponds to amino acid residues 89–126.
Under phospholipid-reconstitution conditions, the human TfR not only integrates
into vesicles, but also forms rosette-like structures called proteoparticles.
Scanning transmission electron microscopy revealed an overall diameter of
31.5 nm and a molecular mass of 1669 ± 26 kDa for the proteoparticles,
corresponding to nine TfR dimers. The average mass of a single receptor dimer
was determined as being 186 ± 4 kDa.
Conclusions:  Proteoparticles resemble TfR exosomes that are expelled by
sheep reticulocytes upon maturation. The structure of proteoparticles in vitro is
thus interpreted as being the result of the TfR’s strong self-association
potential, which might facilitate the endosomal sequestration of the TfR away
from other membrane proteins and its subsequent return to the cell surface
within tubular structures. The stalk is assumed to facilitate the tight packing of
receptor molecules in coated pits and recycling tubuli.
Introduction
In vertebrates the transferrin receptor (TfR) mediates cel-
lular iron uptake upon binding and endocytosis of the
serum iron transport protein transferrin. Within the acidic
microenvironment of early endosomes, iron ions dissociate
from transferrin and are transported into the cytoplasm.
The TfR–apotransferrin complex is separated from other
endocytosed membrane proteins and then recycled back
to the cell surface via a tubular network [1–3].
The expression of TfR is tightly linked to the cellular
free iron concentration by a translational regulatory
mechanism [4,5]. In most somatic cells, the TfR is
degraded slowly with a half life of 14–16 h [6–8]; an addi-
tional fast degradation is found in maturing reticulocytes,
which either expel excess TfR in the form of exosomes
[9] or release the extracellular region by proteolytic
cleavage [10].
The human TfR is a homodimeric membrane protein of
about 190 kDa [10,11]. The cytoplasmic region (residues
1–67) is phosphorylated [12] at Ser24 and palmitoylated
next to the transmembrane domain [13] (residues 68–88)
at Cys62 and Cys67. The large extracellular regions of the
TfR (residues 89–760) are covalently linked by two disul-
fide bridges [14] (Cys89 and Cys98) and carry one
O-linked [15,16] and three N-linked glycans [17].
Whereas the primary structure of the human TfR [18,19],
its posttranslational modifications and its intracellular
trafficking (as reviewed in [20]) have been known for
many years, its three-dimensional structure has not yet
been published. The only successful crystallization
reported [21] was performed with a tryptic fragment com-
prising most of the extracellular part of the receptor
(122–760). Structure determination proved to be
extremely difficult, however, and the work is expected to
be completed soon (CM Lawrence & SC Harrison, per-
sonal communication). Although purified TfR can be
reconstituted into phospholipid vesicles [22–24], no struc-
tural model has been derived from electron microscopy
(EM) data so far.
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Upon reconstituting the purified human TfR into phos-
pholipid vesicles, we had previously observed the forma-
tion of three distinct TfR superstructures: vesicles with
membrane-integrated TfRs, tubular structures and pro-
teoparticles [24]. Proteoparticles appeared as rosette-like
structures in standard negative-stain images and exhibited
a molecular mass exceeding 1000 kDa in gel filtration
experiments [24]. In order to derive a structural model for
the TFR dimer and to elucidate the exact geometry of
TfR proteoparticles, we applied scanning transmission
electron microscopy (STEM) and cryoelectron microscopy
(cryo-EM) to purified and to phospholipid-reconstituted
human TfR. We were able to show that the TfR consists
of a large globular domain (6.4 × 7.5 × 10.5 nm) separated
from the membrane by a 2.9 nm molecular stalk. Addition-
ally, we showed that the receptor forms specific proteopar-
ticles containing, on average, nine receptor dimers.
Results and discussion
STEM analysis of proteoparticles
Proteoparticles do not only form when solubilized receptor
dimers are reconstituted into phospholipid bilayers; they
also appear to be the predominant conformation of purified
TfR in the absence of detergent [23]. Upon adsorption of
detergent-free human TfR onto ultrathin carbon films,
rosette-like structures of uniform size and much smaller
particles that appear to represent isolated receptor dimers
can be visualized by STEM (Figure 1a). A close examina-
tion of the micrographs at higher resolution reveals that the
rosette-like structures are formed by a central density sur-
rounded by eight to ten compact particles of similar size
and shape to the isolated small particles (Figure 1b–d).
The size of the proteoparticles was determined to be
31.5 ± 2.9 nm by analyzing 62 different proteoparticles, as
is described in the materials and methods section.
STEM offers a unique opportunity to determine the mass of
a single macromolecule by measuring the electrons it scat-
ters [25]. The accuracy of this method can be enhanced by
recording a large number of objects and calculating their
mass distribution. Such a mass distribution of 587 randomly
chosen objects from our images is displayed in Figure 2a.
Partitioning the x axis into intervals of 112 kDa, a sharp peak
is found at the left margin and a broad peak at about
1700 kDa. When choosing smaller intervals (Figure 2b), the
left peak appears to be highly symmetric and can be approx-
imated by a Gaussian curve within the selected 0–290 kDa
mass range (r = 0.977). The curve has a maximum at
185.9 kDa, with a standard error of 4.2 kDa (n = 121). This
molecular mass corresponds perfectly with the published
mass range for the human TfR dimer of 180–190 kDa
[11,26–28]. This experimentally derived number was used
to interpret the broad peak displayed in Figure 2a. A Gauss-
ian curve fit (r = 0.948) of 427 particles within the
843–3202 kDa mass range revealed an average proteoparti-
cle mass of 1669 ± 26 kDa. This value corresponds to nine
TfR dimers. The large standard deviation (σ = 533 kDa)
indicates a nonstoichiometric particle composition covering
a range of 9 ± 3 receptor dimers. The mass analysis gives a
more accurate estimate of the average number of receptor
dimers within the proteoparticles than the visual inspection
of the images displayed in Figure 1.
Solution structure of the human TfR in amorphous ice
Most EM techniques rely on the adsorption of the ana-
lyzed macromolecules to the surface of the carbon film and
therefore carry the risk of altering the conformation of the
macromolecules. In addition, staining procedures can
induce distortions and change the apparent shape of the
sample. In contrast, cryo-EM is superior to other EM tech-
niques as it enables the visualization of a thin section of a
shock-frozen sample without artificially induced conforma-
tional distortions [29,30]. Thus, the human TfR was recon-
stituted into phospholipid vesicles and visualized by
cryo-EM (Figure 3). Whereas some large phospholipid
vesicles are bilamellar or multilamellar (open arrow in the
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Figure 1
STEM elastic darkfield signal of TfR proteoparticles. Detergent-free
human TfR sample was adsorbed to carbon-coated copper grids. The
grids were intensively washed with distilled water, negatively stained
with uranyl formate and air-dried. (a) A typical section displaying many
TfR proteoparticles and a few isolated receptor dimers (indicated by
arrows). (b–d) Similar sections at higher magnification. The
proteoparticles consist of about nine receptor dimers, of which some
appear almost bilobular with a small cleft at the outer face (arrows
in d). Scale bars: 50 nm.
top panel, Figure 3), all vesicles with membrane-integrated
TfR are unilamellar and smaller in size (arrowheads in
bottom panels). The few scattered membrane fragments
also contain TfR molecules integrated from both sides
(arrowheads in top panels). Some small vesicles seem to be
in the process of integrating TfR from groups of proteopar-
ticles (thick arrows). Isolated proteoparticles can be found
randomly distributed in all micrographs (thin arrows).
Compared to those seen in the STEM analysis, the pro-
teoparticles in amorphous ice exhibit a similar shape but a
somewhat smaller overall diameter of 28.1 ± 2.4 nm
(Figure 3). Assuming a near spherical shape of the proteop-
articles, this small difference can easily be explained by the
molecular distortion induced in the STEM analysis by the
adsorption to the carbon film. A concurrent dynamic light-
scattering analysis of the same batch of TfR proteoparticles
in aqueous solution revealed a hydrodynamic diameter of
31.0 ± 2.6 nm (J Schüler, Y Georgalis, HF, P Umbach,
W Saenger & RG, unpublished results). Thus, proteoparti-
cles formed upon phospholipid reconstitution of completely
solubilized human TfR and those present in detergent-free
receptor solution are approximately the same size. More-
over, TfR proteoparticles form under many different phos-
pholipid-reconstitution conditions and are stable in most
detergents [24]. We therefore conclude that proteoparticles
constitute a common TfR superstructure that might be sta-
bilized by homophilic protein–protein interactions.
The high solubility of TfR proteoparticles in detergent-
free aqueous solution indicates that the hydrophobic
transmembrane domains of the receptor dimers must be
shielded against the solvent by large hydrophilic regions.
In accordance with the observed size and shape of pro-
teoparticles (Figure 4a) and of the membrane-inserted
receptor dimers (Figure 4c), we therefore propose that the
transmembrane domains of about nine TfR dimers form a
central hydrophobic core surrounded by two hydrophilic
shells, the inner one built by the small cytoplasmic regions
and the outer one by the large extracellular regions of the
receptor (Figure 4b). For symmetry reasons, however, not
all nine receptor dimers can occupy equivalent positions.
Moreover, the hydrophobic core must be assumed to be
structurally less confined, especially as every proteoparti-
cle accommodates, on average, 30.6 phospholipid mol-
ecules [24]. The high stability of proteoparticles and their
nonperfect symmetry would also explain the inability to
grow high-quality crystals from purified human TfR [21].
One could also reason that the lack of a perfect symmetry
facilitates the formation of proteoparticles with a size
range of six to twelve receptor dimers, as indicated by the
broad mass-distribution curve in Figure 2a.
Molecular dimensions of the human TfR dimer
As the arrowheads in Figure 3 indicate, the TfR has a ten-
dency to integrate into the phospholipid bilayer of vesicles
and membrane fragments from both sides. In order to
analyze the structure of isolated TfR dimers, we digitized
the electron micrographs and aligned the images of suitable
membrane sections (Figure 4c). Whereas the large extracel-
lular region (672 residues) of the human TfR is clearly
visible, the tenfold-smaller cytoplasmic region (67 residues)
is not resolved. We show for the first time that a large glob-
ular fraction of the extracellular region of the human TfR is
separated from the membrane at a fixed distance, indicating
the presence of an invisibly thin molecular stalk, as is out-
lined in the model in Figure 4d. The dimensions of the
membrane-inserted TfR dimer were determined by analyz-
ing 72 digitized receptor images. The visible globular
domain of the receptor dimer has an average height (per-
pendicular to the membrane) of 6.4 ± 0.8 nm and a width
(parallel to the membrane) of 9.0 ± 1.5 nm. The molecular
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Figure 2
Mass determination of proteoparticles and single TfR dimers by STEM
darkfield signal analysis of freeze-dried, unstained preparations. The
mass of individual structures was determined as described in the
Materials and methods section. (a) The mass distribution of all
analyzed structures. A Gaussian curve fit of the broad major peak
yielded an average mass for the proteoparticles of 1669 ± 26 kDa
corresponding to nine TfR dimers. Arrowheads mark the standard
deviation of about ± 3 TfR dimers (σ = 533 kDa). (b) The left peak of
(a) at a higher-resolution. The average molecular mass of the particles
was determined to be 185.9 ± 4.2 kDa and corresponds perfectly to
the published mass of the human TfR dimer [11,26–28].
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Structure
stalk linking the globular extracellular domain (gEC) to
the transmembrane domain (TM) has a length of
2.9 ± 0.8 nm. The reconstituted phospholipid bilayer is
6.6 ± 0.5 nm thick.
As a result of the membrane insertion, all receptor heads
are locked at the same distance from the membrane but are
free to rotate about their stalk. Thus, only the height of the
globular domain can be determined accurately; the appar-
ent width represents an average of all angular projections.
Assuming that all molecular dimensions determined by
EM are affected by the same experimental error, the
twofold-larger standard deviation of the width (σ = 1.5 nm)
relative to that of the height of the receptor head (σ = 0.8)
indicates that the width varies by about 3 nm depending
on the projection angle. An ellipsoid with the respective
dimensions of 6.4 × 7.5 × 10.5 nm accommodates 193 kDa
of protein with a density of 1.37 g/ml. The ratio between
the largest and shortest axes of 1.64 is much smaller than
the ratio, deduced by gel filtration, of 3.1 for the large
tryptic fragment of the human TfR [31]. This difference
may be explained by the limits of the gel filtration method,
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Figure 3
Cryo-EM images of membrane-reconstituted
human TfR and single proteoparticles. The
8-POE-solubilized TfR was reconstituted into
preformed SBL vesicles by dialysis and
imaged in vitreous ice over holes in the
carbon support film at 100K. Arrowheads
point to the large extracellular domains of
reconstituted human TfR. In addition to the
membrane-reconstituted receptor molecules,
a number of TfR proteoparticles (thin arrows)
were found that resembled, in size and shape,
those visualized by STEM (Figure 1). Some
vesicles are clustered on one side with
groups of proteoparticles (thick arrows). A
few large unilamellar or multilamellar vesicles
are completely receptor-free (open arrows).
however, because the simultaneously determined axis ratio
of 3.4 for human transferrin [31] is also much larger than
the factor of 2.0 derived from the crystal structure of
human lactoferrin [32], which exhibits 55% amino acid
sequence identity with human transferrin [33].
Defining the stalk region of human TfR
A soluble form of the human TfR, the serum transferrin
receptor, is released in vivo upon proteolytic cleavage [10]
at Arg100. The resulting large fragment of the extracellu-
lar region (residues 101–760) retains both the homodimer-
ization and the ligand-binding activities [34]. In addition,
the purified human TfR is efficiently cleaved by mild
tryptic digestion into a small peptide ending at Arg121 and
a large globular fragment that elutes from a gel filtration
column as a homodimer with an apparent molecular mass
of 151 kDa [31]. This even smaller extracellular fragment
(residues 122–760) still binds transferrin ([31], HF and
RG, unpublished results). As both the serum TfR and the
large tryptic fragment lack the two intermolecular disul-
fide bridges (Cys89 and Cys98) but still remain in the
homodimeric state, the ligand-binding site as well as the
dimer interface must be completely retained in those large
globular fragments. We therefore conclude that the main
function of the region preceding the transmembrane
domain is the formation of a thin stalk that bridges the
gap, seen in the cryo-EM images, between the large glob-
ular domain and the phospholipid bilayer. If this is the
sole function of the stalk domain, however, its amino acid
sequence should have been less conserved during evolu-
tion than those of domains involved in highly specific
protein–protein interactions, such as the large globular
domain. Accordingly, we have compared the protein
sequence of human TfR with all three published TfR
sequences from other vertebrates: mouse [35,36], hamster
[37] and chicken [38]. The result of this analysis is shown
in Figure 5, which illustrates the chemical similarity
between human and chicken TfRs. Most strikingly, the
extracellular region directly following the transmembrane
domain (S1, residues 89–126) was found to be the least
conserved region of the entire protein. This region con-
tains the two intermolecular disulfide bridges (Cys89 and
Cys98) and both proteolytic-cleavage sites (Arg100 and
Arg121). Further towards the C terminus, a second
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Figure 4
Images and models of proteoparticles and
membrane-reconstituted human TfR. Cryo-
electron-microscopic images of
proteoparticles and membrane fragments
were digitized and analyzed as described.
(a) Four typical proteoparticles. (b) A
proteoparticle model. (c) Two typical
membrane fragments. (d) The corresponding
model. Proteoparticles and receptor dimers
inserted from opposite sides into the
membrane have similar cross-sections of
28.1 nm and 26.2 nm, respectively. Scale
bars: 25 nm.
Structure
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Figure 5
Comparison of the amino acid sequences of
human TfR and the TfR from chicken. The
cytoplasmic domain (CP), the transmembrane
domain (TM), the proposed stalk domains (S1,
S2) and the globular extracellular domain
(gEC) of human TfR were compared to the
respective chicken TfR domains. The domain-
specific average chemical sequence similarity
is plotted against the amino acid position of
human TfR. The dotted line represents the
average chemical sequence similarity of the
whole protein. The sequence regions that
correspond to the major tryptic fragment and
to the serum TfR are indicated. 0
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Structure
domain (S2, residues 127–155) that exhibits an intermedi-
ate level of interspecies conservation was identified. We
therefore propose that the S1 domain corresponds to the
molecular stalk, whereas the S2 domain forms a transition
domain between the stalk and the large globular domain.
This conclusion is further supported by the fact that
similar results were obtained in all possible sequence com-
parisons, irrespective of whether amino acid identities or
chemical similarities were considered (Table 1).
Structural model of the human TfR
As previously described, the TfR consists of a small cyto-
plasmic region containing an internalization signal, a
single transmembrane domain and a large extracellular
domain [13,18,19,39]. A combination of cryo-EM analysis
and comparative sequence interpretation has now
allowed us to derive a low-resolution picture of the orga-
nization of the TfR molecule (Figure 6). The proposed
model not only accounts for a number of published struc-
tural results, but also allows us to explain a number of
biochemical observations. The molecular stalk separates
the receptor head from the lipid bilayer by 2.9 nm. This
stalk region is easily accessible to proteases but appears
to be partially protected by the O-glycosylation of
Thr104, which interferes with the proteolytic event that
produces the serum TfR [40]. The secondary structure of
the stalk region is unlikely to be a continuous α helix
because four proline residues are located at positions 94,
107, 112 and 117, the last of these being conserved
among mammals. The two globular extracellular domains
of the TfR dimer contain both the homodimerization site
and the transferrin-binding site. They form a well-
resolved, large globular domain with a size of
6.4 × 7.5 × 10.5 nm. The stalk is not required for dimer
formation and it contains two disulfide bonds that are
neither essential for receptor biosynthesis nor for trans-
port of the receptor to the cell surface [14]. As both disul-
fide bonds are located very close to the membrane, they
may rather be important for keeping the transmembrane
domains of the receptor dimer attached.
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Table 1
Domain-specific sequence comparison of human TfR with TfR from chicken, mouse and hamster.
Human to chicken Human to mouse Human to hamster
Domain hTfR residues Amino acid Chemical Amino acid Chemical Amino acid Chemical
identity similarity identity similarity identity similarity
Overall identity (%)
All domains 1–760 49.9 62.8 75.8 84.7 78.5 86.5
Local difference identity
CP* 1–67 5.0 –0.8 12.3 4.9 5.1 0.1
TM† 68–88 2.4 8.6 –9.1 5.8 7.2 13.5
S1‡ 89–126 –34.3 –39.3 –25.8 –29.7 –32.3 –32.6
S2‡ 127–155 –25.8 –21.4 –17.1 –12.3 –23.3 –24.4
gEC§ 156–760 3.4 4.0 1.5 1.8 2.4 2.8
*Cytoplasmic domain. †Transmembrane domain. ‡Possible spacer segments. §Globular extracellular domain.
Figure 6
Transferrin receptor model. (a) Average
dimensions of the receptor dimer derived by
EM image analysis. (b) Structural model
incorporating additional biochemical data
(see Results and discussion section). The
receptor dimer is shown in two projections
that are perpendicular to each other. Several
covalent modifications of the receptor
referred to in the text are also indicated.
Independent data suggest that the disulfide
bonds (black bars), the O-glycans (yellow
hexagons), and the protease cleavage sites
(arrows) are part of a molecular stalk that is
formed by amino acids 89–126 of the
receptor. YTRF (single-letter amino acid
code), is the internalization motif of the TfR.
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Biological implications
Upon phospholipid reconstitution of the human transfer-
rin receptor (TfR), we have previously observed tubuli
and rosette-like structures called proteoparticles [24], in
addition to vesicles. In order to understand the structural
basis for this unexpected structural heterogeneity of TfR
and to draw further biological conclusions, we have now
analyzed membrane-inserted and proteoparticle-bound
human TfR with electron-microscopic (EM) methods.
In sheep, the TfR is expelled from reticulocytes during
maturation in the form of round bodies with 50 nm diame-
ter [41]. Negative-stain EM images of these round bodies
resemble, in size and shape, our cryo-EM images of
vesicle-associated proteoparticles. The close association of
the proteoparticles and the presence of obvious transition
states suggest a dynamic transition between proteoparti-
cles and membrane-inserted TfR. This observation and
the unusual stability of TfR proteoparticles could therefore
reflect an intrinsic self-association potential of TfR being
utilized during sheep reticulocyte maturation. Further-
more, recent light-scattering experiments indicate a ten-
dency of the human TfR proteoparticles to form larger
clusters upon either deglycosylation or solvent acidifica-
tion (J Schüler, Y Georgalis, HF, P Umbach, W Saenger
& RG, unpublished results). This induced self-association
may be linked to the observed separation of TfR from
other endocytosed membrane proteins and to its subse-
quent return to the cell surface within tubular structures.
Upon purifying TfR from different subcellular fractions,
Turkewitz and Harrison [42] had previously observed
that receptor molecules derived from coated vesicles self-
associated into larger aggregates of unspecified size. On
the basis of their observations, they had already con-
cluded that the lower pH within coated vesicles could
trigger a specific self-association process that might be
involved in receptor sorting. Our current findings together
with the results of our light-scattering experiments
(J Schüler, Y Georgalis, HF, P Umbach, W Saenger &
RG, unpublished results) support this hypothesis.
An unexpected finding is the observation that the
human TfR seems preferentially to integrate into vesi-
cles with a diameter of between 60 and 160 nm, whereas
larger vesicles remain essentially receptor-free. It is
interesting to note that this preferred size resembles that
of plasma-membrane-derived coated vesicles (100 nm
diameter) and endosomal TfR-containing clathrin-
coated buds (60 nm) [3]. This selective affinity of the
human TfR for vesicles of a certain size further sup-
ports the suggestion that the TfR self-association poten-
tial is linked to sorting events along its intracellular path.
Our discovery of a molecular spacer of 2.9 nm that
keeps the TfR ligand-binding domain at a constant
distance from the membrane suggests an important
function that might be shared by other endocytic recep-
tors. The ‘stalk’ increases the motion of the ligand-
binding site relative to the membrane. On the one hand,
mobility of the ligand-binding site could increase the
ligand-association rate and, on the other, it could help to
accommodate the receptor–ligand complex in the
narrow tubules of the recycling pathway.
Materials and methods
Octyl(polydisperse)oligooxyethylene (8-POE) was obtained from the
W. Kolb AG (Hedingen, Switzerland). CHAPS (3-[(3-cholamido-
propyl)dimethylammonio]-1-propanesulfonate), soy bean lecithin
(SBL) and human transferrin were purchased from Sigma (St. Louis,
MO, USA). Human placental transferrin receptor (TfR) was purified
by ligand affinity chromatography [31] with the modifications
described recently [24].
Reconstitution of TfR in soy bean lecithin vesicles
The TfR (200 µg) was pre-incubated for 30 min in 900 µL of 1.11-fold
concentrated TBS (Tris/HCl-buffered saline: 100 mM NaCl, 50 mM
Tris(hydroxymethyl)-aminomethane, pH 8.0) containing 1% 8-POE. This
detergent had been found to completely solubilize TfR [24]. Preformed
SBL vesicles were prepared on ice by sonicating an aqueous suspen-
sion of SBL with a Branson Sonifier B-12 (Danbury, Connecticut, USA)
for 30 s intervals (intensity setting: 5) until the milky lipid suspension
became weakly translucent. Subsequently, the solution was diluted to
20 mg/ml phospholipid. The solubilized protein (900 µl) was mixed with
the phospholipid solution (100 µl) and incubated for 1 h at room tem-
perature. Reconstitution was performed at 4°C by dialyzing the sample
five times for 3 h against 1 l of TBS. After reconstitution, all samples
were centrifuged at 100,000 × g for 2 h at 8°C. The pellets were resus-
pended in 200 µl TBS and homogenized in a precision Potter homoge-
nizer with a Teflon pestle (Kontes, Vineland, NJ, USA).
Scanning transmission electron microscopy (STEM)
Copper grids (200-mesh) were coated with thick fenestrated carbon
films prepared according to the method of Fukami and Adachi [43]. In
a second step, the fenestrated carbon films were covered with a thin
closed carbon film to yield a thin specimen support. Glow discharge in
air was used to enhance protein adsorption. 5 µl TfR solution (85 µg/ml
in phosphate-buffered saline — 150 mM NaCl, 10 mM phosphate,
pH 7.5) was adsorbed to each grid for 1 min. To remove any salt that
could affect the mass determination [44], the grids were washed five
times on water droplets and were blotted between each wash step.
After washing, the grids were either negatively stained with uranyl
formate or blotted, frozen in liquid nitrogen and freeze-dried overnight
at –80°C in the pretreatment chamber of the Vacuum Generator’s
HB-5 scanning transmission electron microscope. The sample was
scanned with an electron beam focused to less than 1 nm diameter.
The elastic dark-field signal was determined for each raster point by
counting the elastically scattered electrons at large angles by an
annular detector.
Mass determination of proteoparticles and single TfR dimers
The darkfield counts were stored on a hard disk and used for mass
determination by a specialized software package (IMPSYS) as
described previously [44,45]. To this end, the circumference of pro-
teoparticles and TfR dimers were contoured at a given threshold inten-
sity, the signal integrated, the background subtracted and the resulting
value normalized to the recording dose [44]. Mass values thus
obtained were displayed in histograms to which Gaussian profiles
could be fitted.
Cryo-electron microscopy
Grids with uncovered thick fenestrated carbon films were prepared as
described above and mounted in a shock-freeze chamber adjusted to
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25°C and 90% relative humidity. SBL-reconstituted TfR (5 µl) was
applied to the grid inside the chamber and incubated for 1 min. After
removing excess buffer by paper blotting, the remaining aqueous solu-
tion spanning the holes of the carbon film was shock frozen to amor-
phous ice by dropping the whole grid holder into liquid ethane kept at
90K. All subsequent steps were performed well below 120K, within a
nitrogen atmosphere. If required, sample grids were stored in liquid
nitrogen. For cryo-EM, the grids were transferred into an electron micro-
scope 902 Cryo (Zeiss, Oberkochen, Germany) and analyzed at 100K.
Focusing was performed at a 140,000-fold magnification using the
minimal-dose focusing system to avoid beam damage to the frozen
sample. Cryo-EM images were recorded at 50,000-fold magnification by
exposing a high-resolution film (SO-163, Kodak) for a maximum of 1 s.
Image analysis
Threefold magnified prints of cryo-EM images were scanned at 600 dpi
and digitized on an eight-bit grayscale (Agfa-Gaevert StudioScan II).
Images of single proteoparticles and membrane fragments were, if nec-
essary, contrast enhanced and aligned. Size determination of the struc-
tures was performed by measuring a large number of images and
averaging the obtained distances. The overall diameter of proteoparti-
cles was determined by fitting circles or ellipses to 62 different pro-
teoparticles. Ellipses were used sometimes because proteoparticles
are not perfectly regular in their shape. Indeed, the measurement
revealed an average deviation from a circular shape of 2.4 nm or 7.6%.
The thickness of the membrane, the diameter of the globular domain
and the length of the TfR stalk were derived from 72 clearly visible mol-
ecules integrated in aligned membrane fragments.
Amino acid sequence analysis
Amino acid sequences were derived from the EMBL/GenBank/DDBJ
Databases. The protein sequence of human TfR was aligned to those of
chicken [38], mouse[35,36], and hamster [37] using the MacMolly Tetra
software package (version 2.1, Soft Gene GmbH, Berlin, Germany). The
similarity of the three major parts of the protein — the cytoplasmic region,
the transmembrane domain and the extracellular region — was quantified
by calculating the respective amino acid identity and the chemical simi-
larity according to the definitions of Kruskal [46].
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